Clinical trial
Ultrasound-Guided Stellate Ganglion Block With Botulinum Toxin Versus Steroid in Refractory Bell's Palsy
NCT05099835 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Ultrasound-Guided Stellate Ganglion Block With Botulinum Toxin Versus Steroid in Refractory Bell's Palsy
- Lead sponsor
- Assiut University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 1, 2021
- Completion date
- July 1, 2022
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
change from baseline house-brackmann